Analyst Ratings for Seattle Genetics (sgen)

sgen Rating Summary

sgen Price Target Summary

* Over Last 12-Mos
  |   Expand Research on sgen
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $51.00 (+19.7%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
7/9/2014 UBS Upgrade Buy
(Neutral)
N/A
(N/A)
35.46 42.62 20.19% Details
5/6/2014 BofA/Merrill Lynch Upgrade Neutral
(Underperform)
N/A
(N/A)
35.10 42.62 21.42% Details
Like SGEN Ratings? Also take a look at NDAQ, ISIS, FSLR, MDVN

SGEN Ratings News